|
|
||||||||
1 Division of Clinical
Pharmacology and Toxicology, It has been proposed that the hepatocellular
Na+-dependent bile salt uptake
system exhibits a broad substrate specificity in intact hepatocytes. In
contrast, recent expression studies in mammalian cell lines have
suggested that the cloned rat liver Na+-taurocholate cotransporting
polypeptide (Ntcp) may transport only taurocholate. To characterize its
substrate specificity Ntcp was stably transfected into Chinese hamster
ovary (CHO) cells. These cells exhibited saturable
Na+-dependent uptake of
[3H]taurocholate
[Michaelis constant
(Km) of ~34
µM] that was strongly inhibited by all major bile salts,
estrone 3-sulfate, bumetanide, and cyclosporin A. Ntcp cRNA-injected
Xenopus
laevis oocytes and the transfected CHO
cells exhibited saturable
Na+-dependent uptake of
[3H]taurochenodeoxycholate
(Km of ~5
µM),
[3H]tauroursodeoxycholate
(Km of ~14
µM), and
[14C]glycocholate
(Km of ~27
µM). After induction of gene expression by sodium butyrate,
Na+-dependent transport of
[3H]estrone 3-sulfate
(Km of ~27
µM) could also be detected in the transfected CHO cells. However,
there was no detectable
Na+-dependent uptake of
[3H]bumetanide or
[3H]cyclosporin A. These results show that the cloned Ntcp can mediate Na+-dependent uptake of all
physiological bile salts as well as of the steroid conjugate estrone
3-sulfate. Hence, Ntcp is a multispecific transporter with preference
for bile salts and other anionic steroidal compounds.
sodium-dependent bile salt transport; organic anion; multispecificity
UPTAKE OF ORGANIC ANIONS such as bile salts from blood
into hepatocytes is mediated by
Na+-dependent as well as
Na+-independent transport systems
(7). Previous kinetic uptake and inhibition studies in several
experimental systems have indicated that the hepatocellular
Na+-dependent bile salt uptake
system exhibits a broad substrate specificity for a wide variety of
amphipathic organic molecules, including conjugated bile salts,
electroneutral steroids, cyclic oligopeptides, and a number of drugs,
such as bumetanide and cyclosporin A (3, 14, 22). In contrast, recent
expression studies in the liver-derived immortalized cell line HPCT-1E3
have suggested that the cloned rat liver
Na+-taurocholate cotransporting
polypeptide (Ntcp) may exclusively transport taurocholate and that
other transport systems, such as epoxide hydrolase, account for
Na+-dependent uptake of cholate
and glycocholate into rat hepatocytes (15, 21). Because Ntcp is thought
to represent a major bile salt transport system in mammalian liver (8)
and because only taurocholate has been used as a transport substrate in
previous Ntcp expression studies (15, 19), we have reexamined the
substrate specificity of Ntcp in more detail in cRNA-injected
Xenopus
laevis oocytes and in transfected
Chinese hamster ovary (CHO) cells. The results clearly demonstrate that
Ntcp transports typical natural di- and trihydroxy-conjugated bile
salts, as well as, albeit to a lesser degree, the steroid conjugate
estrone 3-sulfate.
Materials.
[3H]taurocholic acid
(2.6 Ci/mmol),
[3H]cholic acid (13.2 Ci/mmol),
[14C]glycocholic acid
(44.6 mCi/mmol), and
[3H]estrone 3-sulfate
(49.0 Ci/mmol) were obtained from DuPont-New England Nuclear (Boston,
MA). [3H]cyclosporin A
(11.1 Ci/mmol) was purchased from Amersham International (Little
Chalfont, Buckinghamshire, UK).
[3H]taurochenodeoxycholic
acid (0.5 Ci/mmol) and
[3H]tauroursodeoxycholic
acid (0.5 Ci/mmol) were conjugated as described previously (11).
[3H]bumetanide was
kindly provided by E. Petzinger of Justus Liebig-Universität (Giessen, Germany). All cell culture media and reagents were obtained from Life Technologies (Paisley, UK). All other chemicals and reagents
were of analytical grade and were readily available from commercial
sources.
Expression of Ntcp in Xenopus
laevis oocytes.
Xenopus
laevis oocytes were prepared as
described previously (8). After an overnight incubation at 18°C,
healthy oocytes were injected with 2.5 ng of Ntcp cRNA or water. After
3 days in culture, uptake of the indicated substrates was measured at 25°C in a medium containing 100 mM NaCl or choline chloride,
2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and
10 mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid/tris(hydroxymethyl)aminomethane, pH 7.5, as described previously (6).
Stable transfection of CHO cells with Ntcp.
Wild-type CHO cells (CHO-K1) were stably transfected with the coding
region of the rat Ntcp (9) subcloned into vector pCMV vector-1 as
previously described (18). The vector pCMV vector-1 contains the strong
cytomegalovirus promoter-enhancer unit excised from pcDNA1/NEO
(Invitrogen) and subcloned for user convenience into pBluescript
(Stratagene, La Jolla, CA), which also contained a
Xenopus-rabbit 5'-untranslated leader, the
rabbit Cell culture.
CHO cells were grown in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum, 2 mM
L-glutamine, 50 µg/ml L-proline, 100 U/ml penicillin,
100 µg/ml streptomycin, and 0.5 µg/ml Fungizone (amphotericin B) at
37°C with 5% CO2 and 95%
humidity. Selective media contained an additional 400 µg/ml G418-sulfate (Geneticin).
Uptake studies in CHO cells.
For the determination of
Na+-dependent uptake of potential
substrates for Ntcp, the cells were grown to confluency on 35-mm dishes
and rinsed three times with prewarmed (37°C) sodium or choline
containing Earle's balanced saline solution (16) supplemented with 5.5 mM D-glucose. The cells were
then incubated at 37°C in the presence of radiolabeled substrate.
After the indicated time interval, the transport was stopped with 3 ml
of ice-cold Na+-containing Earle's solution. After two
additional washing steps with the same stop solution, the cells were
solubilized in 1 ml of 1% Triton X-100 and mixed with 5 ml of
scintillation fluid (Ultima Gold; Canberra Packard International,
Zurich, Switzerland). Radioactivity was determined in a Packard
Tri-Carb 2200 CA liquid scintillation counter (Canberra Packard). For
some experiments, expression of Ntcp was induced by incubating the
cells for 24 h with culture medium supplemented with 5 mM butyrate as
described previously (13).
To evaluate the proposed broad substrate specificity of Ntcp in a
stably transfected cell line, we constructed an expression vector by
inserting the coding region of Ntcp into pCMV vector-1 (18) and
electroporated the resulting construct into CHO cells. Several
G418-resistant cell clones were isolated using cloning cylinders and
tested for Na+-dependent
taurocholate uptake. Clone CHO 9-6 exhibited the highest transport
activity.
Time-dependent uptakes of taurocholate in wild-type and Ntcp-expressing
CHO cells are compared in Fig. 1. Wild-type
cells (Fig. 1A) showed no
significant Na+-dependent
transport of taurocholate, reflecting the absence of Ntcp in these
cells. In contrast, Ntcp-expressing CHO 9-6 cells (Fig.
1B) showed a strong intracellular
accumulation of taurocholate in the presence, but not in the absence,
of Na+. As shown in Fig.
2, the
Na+-dependent taurocholate uptake
portion was strongly inhibited by cholate, taurodeoxycholate,
taurochenodeoxycholate (TCDC), tauroursodeoxycholate (TUDC), the
sulfate-conjugated steroids estrone 3-sulfate and
17
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-globin poly(A) signal, and a gastrin gene transcription stop
signal. From the resulting transfected cell pool, single
clones were isolated using cloning cylinders and tested for
Na+-dependent transport of
taurocholate. The best transporting clone (CHO 9-6) was selected and
used for all further experiments.
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
-estradiol 3-sulfate, and the drugs bumetanide and cyclosporin
A. Inhibition by the unconjugated steroids such as
testosterone and progesterone was less pronounced.

View larger version (11K):
[in a new window]
Fig. 1.
Time course of Na+-dependent
taurocholate uptake into Chinese hamster ovary (CHO) cells. Wild-type
(CHO-K1; A) or
Na+-taurocholate cotransporting
polypeptide (Ntcp)-expressing (CHO 9-6;
B) CHO cells were
incubated with 2.5 µM
[3H]taurocholate at
37°C for the indicated time periods in the presence (
) and
absence (
) of an inwardly directed NaCl gradient. Data points
represent means ± SD of triplicate determinations.

View larger version (19K):
[in a new window]
Fig. 2.
Cis-inhibition of
Na+-dependent taurocholate
transport in Ntcp-expressing CHO 9-6 cells. CHO cells were incubated
for 1 min at 37°C with 2.5 µM
[3H]taurocholate and
indicated concentrations of inhibitors in the presence and absence of
an inwardly directed NaCl gradient. Net
Na+-dependent uptake (uptake in
the presence minus the absence of NaCl) in the absence of inhibitors is
expressed as 100% (control). Results represent means ± SE and are
given as %control. Differences were evaluated using Student's
t-test.
* P < 0.01, ** P < 0.001 vs. control. TDC,
taurodeoxycholate; TCDC, taurochenodeoxycholate; TUDC,
tauroursodeoxycholate.
To test whether the cis-inhibiting substrates are also transported by Ntcp, we performed uptake studies in the Xenopus laevis oocyte expression system. As summarized in Table 1, Na+-dependent transport of all tested bile salts was stimulated between 10- and 100-fold in cRNA-injected oocytes. In contrast, Na+-dependent uptake of radiolabeled estrone 3-sulfate was stimulated only twofold, and no Na+-dependent uptake was observed for bumetanide and cyclosporin A. Similar results were also obtained in stably transfected CHO 9-6 cells. As depicted in Fig. 3, both TCDC and TUDC accumulated in an Na+-dependent manner in Ntcp-expressing CHO 9-6 cells, whereas no significant Na+-dependent uptake was seen in wild-type CHO-K1 cells. Because Na+-dependent uptake of glycocholate was only minimally stimulated in uninduced CHO 9-6 cells (Fig. 4), we induced gene expression by 24 h preincubation with 5 mM sodium butyrate (13). As can be seen in Fig. 4, butyrate induction resulted in an ~10-fold increase in the expressed Na+-dependent glycocholate uptake rate, whereas no effect of butyrate was seen on Na+-independent uptake. In contrast, wild-type CHO-K1 cells did not show any Na+-dependent accumulation of glycocholate even after butyrate induction (Fig. 4).
|
|
Finally, we measured uptake of the
cis-inhibiting substrate estrone
3-sulfate and determined the kinetics of substrate uptake in
butyrate-induced Ntcp-expressing CHO 9-6 cells. As in oocytes (Table 1)
there was again a clear
Na+-dependent estrone 3-sulfate
transport in the CHO 9-6 cells (Fig. 5), whereas wild-type CHO-K1
cells showed no Na+-dependent
transport signal. Furthermore,
Na+-dependent uptake of estrone
3-sulfate and various bile salts exhibited clear saturability with the
highest affinity for TCDC, followed by TUDC > glycocholate = estrone
3-sulfate = taurocholate (Table 2). In
contrast, several attempts failed to demonstrate Na+-dependent uptake of bumetanide
and cyclosporin A in butyrate-induced Ntcp-expressing CHO 9-6 cells. No
difference in bumetanide (1 µM) uptake was found in the presence
(1.42 ± 0.17 pmol · min
1 · mg
protein
1) and absence
(1.30 ± 0.18 pmol · min
1 · mg
protein
1) of
Na+ in transfected CHO cells. For
cyclosporin A (1 µM) similar uptakes were found in transfected (175 ± 23 and 126 ± 9 pmol · min
1 · mg
protein
1 for NaCl and
choline chloride, respectively) and in wild-type (172 ± 21 and 128 ± 9 pmol · min
1 · mg
protein
1 for NaCl and
choline chloride, respectively) CHO cells. These results are similar to
the data obtained in injected Xenopus
laevis oocytes (Table 1). They prove the universal
nature of Ntcp as a bile salt carrier and document its relative broad
substrate specificity. However, the data also indicate that not all
cis-inhibiting substrates are also
transport substrates of Ntcp, thus emphasizing the need for direct
transport studies rather than kinetic inhibition studies for the
correct determination of the substrate specificity of a single carrier
protein.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Previous kinetic inhibition studies with hepatocytes and isolated rat liver basolateral membrane vesicles have provided evidence for a rather broad substrate specificity of the hepatocellular Na+-dependent bile salt uptake system (3, 14, 22). However, these transport studies in intact cells and isolated membrane vesicles could not distinguish between the presence of a single multispecific or several monospecific transport systems. To discriminate between these two possibilities, the involved transporting polypeptides must be isolated and transfected into a cell line that does not constitutively express the respective transport function. Although functional expression of Ntcp in Xenopus laevis oocytes (9) as well as in various mammalian cell lines (2, 15, 18, 19) has clearly established its function as an Na+-dependent taurocholate uptake system, recent experiments in stably transfected HPCT-1E3 cells have suggested that Ntcp might not transport other bile salts such as glycocholate and cholate (15). In fact, additional Na+-dependent bile salt transporting polypeptides, such as microsomal epoxide hydrolase (21), have been postulated to contribute to the obvious multispecificity of the Na+-dependent bile salt uptake function of rat hepatocytes (20).
Contrary to these suggestions, the present study demonstrates that besides taurocholate, Ntcp also mediates transport of cholate, glycocholate, TCDC, and TUDC (Tables 1 and 2; Figs. 3 and 4). These results indicate that Ntcp can transport all cis-inhibiting bile salt derivatives (Fig. 2), although the extent of Ntcp-mediated transport is different for various bile salts. Thus, based on the ratio of the maximum velocity (Vmax) to the Michaelis constant, the best transport substrate of Ntcp was TCDC followed by TUDC, taurocholate, estrone 3-sulfate, and glycocholate (Table 2). These data are consistent with the previously observed higher affinity of Na+-dependent dihydroxy-conjugated bile salt uptake compared with trihydroxy-conjugated bile salt uptake in isolated hepatocytes (1, 20). Furthermore, the kinetic data presented in Table 2 demonstrate that maximal Na+-dependent bile salt uptake in butyrate-induced Ntcp-expressing CHO 9-6 cells was as high as in short-term cultured hepatocytes (19), indicating that the adopted CHO cell system represents a suitable model for the correct delineation of the substrate specificity of Ntcp.
In addition to various physiological bile salts, the cis-inhibiting compound estrone 3-sulfate (Fig. 2) was also transported by Ntcp with an affinity similar to that of bile salts (Table 2) in butyrate-induced CHO 9-6 cells (Fig. 5), indicating that the substrate specificity of Ntcp indeed extends beyond bile salts as previously suggested in functional transport studies in isolated basolateral membrane vesicles (22). However, in comparison with bile salts, the Ntcp-mediated Na+-dependent uptake portion of estrone 3-sulfate is small (Table 1). In transfected CHO 9-6 cells it could only be detected after butyrate-induced gene expression, indicating that the level of Ntcp expression is a critical factor for correct delineation of the true substrate specificity of Ntcp. In this regard, it is important to realize that even after butyrate induction, the transfected CHO 9-6 cells still expressed an approximately threefold lower Vmax value for Na+-dependent taurocholate uptake compared with freshly isolated hepatocytes (1). Hence, it cannot be definitely excluded that at higher expression levels Ntcp might also transport the cis-inhibiting substrates bumetanide and cyclosporin A (Fig. 2). However, this possibility appears unlikely, since bumetanide transport is encoded by a different rat liver mRNA species (10) and cyclosporin A exhibited noncompetitive inhibition of Na+-dependent taurocholate uptake in isolated rat liver basolateral plasma membrane vesicles (22). The present study nevertheless demonstrates that the achieved expression level in butyrate-induced CHO 9-6 cells was sufficient to extend the substrate specificity of Ntcp to various physiological bile salts and to the estrogen conjugate estrone 3-sulfate. Because Ntcp expression is decreased in various forms of cholestatic liver disease (4, 5, 17), its downregulation may be associated with a continuous narrowing of the spectrum of transported substrates also in vivo. Our results indicate that even at low expression levels Ntcp would still maintain its transport preference for taurine-conjugated bile salts, whereas its less well-transported substrates could still be transported across the sinusoidal membrane of cholestatic hepatocytes by Na+-independent systems, including members of the organic anion transporting polypeptide gene (oatp) family of transporters (12).
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by Swiss National Science Foundation Grants 31-45536.95 and 31-45677.95 (to P. J. Meier and B. Hagenbuch). Work at the University of California San Diego was supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-21506 as well as by a Grant-in-Aid from the Falk Foundation (Freiburg, Germany). B. Hagenbuch is a recipient of a Cloëtta Foundation Fellowship.
| |
FOOTNOTES |
|---|
A preliminary report of this study was presented at the annual meeting of the American Gastroenterological Association in New Orleans, in May 1994, and was published previously in abstract form (Gastroenterology 106: A979, 1994).
Address for reprint requests: B. Hagenbuch, Division of Clinical Pharmacology and Toxicology, Dept. of Medicine, Univ. Hospital, CH-8091 Zurich, Switzerland.
Received 16 June 1997; accepted in final form 30 October 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bellantani, S.,
W. G. M. Hardison,
P. Marchegiano,
G. Zanasi,
and
F. Manenti.
Bile acid inhibition of taurocholate uptake by rat hepatocytes: role of OH groups.
Am. J. Physiol.
252 (Gastrointest. Liver Physiol. 15):
G339-G344,
1987
2.
Boyer, J. L.,
O. C. Ng,
M. Ananthanarayanan,
A. F. Hofmann,
C. D. Schteingart,
B. Hagenbuch,
B. Stieger,
and
P. J. Meier.
Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells.
Am. J. Physiol.
266 (Gastrointest. Liver Physiol. 29):
G382-G387,
1994
3.
Frimmer, M.,
and
K. Ziegler.
The transport of bile acids in liver cells.
Biochim. Biophys. Acta
947:
75-99,
1988[Medline].
4.
Gartung, C.,
M. Ananthanarayanan,
M. A. Rahman,
S. Schuele,
S. Nundy,
C. J. Soroka,
A. Stolz,
F. J. Suchy,
and
J. L. Boyer.
Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis.
Gastroenterology
110:
199-209,
1996[Medline].
5.
Green, R. M.,
D. Beier,
and
J. L. Gollan.
Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.
Gastroenterology
111:
193-198,
1996[Medline].
6.
Hagenbuch, B.,
H. Lübbert,
B. Stieger,
and
P. J. Meier.
Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes.
J. Biol. Chem.
265:
5357-5360,
1990
7.
Hagenbuch, B.,
and
P. J. Meier.
Sinusoidal (basolateral) bile salt uptake systems of hepatocytes.
Semin. Liver Dis.
16:
129-136,
1996[Medline].
8.
Hagenbuch, B.,
B. F. Scharschmidt,
and
P. J. Meier.
Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes.
Biochem. J.
316:
901-904,
1996.
9.
Hagenbuch, B.,
B. Stieger,
M. Foguet,
H. Lübbert,
and
P. J. Meier.
Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.
Proc. Natl. Acad. Sci. USA
88:
10629-10633,
1991
10.
Honscha, W.,
K. Schulz,
D. Müller,
and
E. Petzinger.
Two different messenger RNAs from rat liver code for the transport of bumetanide and taurocholate in Xenopus laevis oocytes.
Eur. J. Pharmacol.
246:
227-232,
1993[Medline].
11.
Kullak-Ublick, G. A.,
B. Hagenbuch,
B. Stieger,
C. D. Schteingart,
A. F. Hofmann,
A. W. Wolkoff,
and
P. J. Meier.
Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver.
Gastroenterology
109:
1274-1282,
1995[Medline].
12.
Meier, P. J.,
U. Eckhardt,
A. Schroeder,
B. Hagenbuch,
and
B. Stieger.
Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver.
Hepatology
26:
1667-1677,
1997[Medline].
13.
Palermo, D. P.,
M. E. DeGraaf,
D. R. Marotti,
E. Rehberg,
and
L. E. Post.
Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression.
J. Biotechnol.
19:
35-48,
1991[Medline].
14.
Petzinger, E.
Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport.
Rev. Physiol. Biochem. Pharmacol.
123:
47-211,
1994[Medline].
15.
Platte, H. D.,
W. Honscha,
K. Schuh,
and
E. Petzinger.
Functional characterization of the hepatic sodium-dependent taurocholate transporter stably transfected into an immortalized liver-derived cell line and V79 fibroblasts.
Eur. J. Cell Biol.
70:
54-60,
1996[Medline].
16.
Rabito, C. A.,
and
M. V. Karish.
Polarized amino acid transport by an epithelial cell line of renal origin (LLC-PK1). The apical system.
J. Biol. Chem.
258:
2543-2547,
1983
17.
Simon, F. R.,
J. Fortune,
M. Iwahashi,
C. Gartung,
A. Wolkoff,
and
E. Sutherland.
Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters.
Am. J. Physiol.
271 (Gastrointest. Liver Physiol. 34):
G1043-G1052,
1996
18.
Stieger, B.,
B. Hagenbuch,
L. Landmann,
M. Höchli,
A. Schroeder,
and
P. J. Meier.
In situ localization of the hepatocytic Na+/taurocholate cotransporting polypeptide (Ntcp) in rat liver.
Gastroenterology
107:
1781-1787,
1994[Medline].
19.
Torchia, E. C.,
R. J. Shapiro,
and
L. B. Agellon.
Reconstitution of bile acid transport in the rat hepatoma McArdle RH-7777 cell line.
Hepatology
24:
206-211,
1996[Medline].
20.
Van Dyke, R. W.,
J. E. Stephens,
and
B. F. Scharschmidt.
Bile acid transport in cultured rat hepatocytes.
Am. J. Physiol.
243 (Gastrointest. Liver Physiol. 6):
G484-G492,
1982
21.
Von Dippe, P.,
M. Amoui,
R. H. Stellwagen,
and
D. Levy.
The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase.
J. Biol. Chem.
271:
18176-18180,
1996
22.
Zimmerli, B.,
J. Valantinas,
and
P. J. Meier.
Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.
J. Pharmacol. Exp. Ther.
250:
301-308,
1989
This article has been cited by other articles:
![]() |
S. Mita, H. Suzuki, H. Akita, H. Hayashi, R. Onuki, A. F. Hofmann, and Y. Sugiyama Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G550 - G556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mita, H. Suzuki, H. Akita, B. Stieger, P. J. Meier, A. F. Hofmann, and Y. Sugiyama Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G159 - G167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hata, P. Wang, N. Eftychiou, M. Ananthanarayanan, A. Batta, G. Salen, K. S. Pang, and A. W. Wolkoff Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G829 - G839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O. Elferink Cholestasis Gut, May 1, 2003; 52(90002): ii42 - 48. [Abstract] [Full Text] |
||||
![]() |
M. E. Mendoza, M. J. Monte, M. A. Serrano, M. Pastor-Anglada, B. Stieger, P. J. Meier, M. Medarde, and J. J. G. Marin Physiological characteristics of allo-cholic acid J. Lipid Res., January 1, 2003; 44(1): 84 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tan and K. S. Pang Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes Drug Metab. Dispos., March 1, 2001; 29(3): 335 - 346. [Abstract] [Full Text] |
||||
![]() |
R. Yumoto, T. Murakami, M. Sanemasa, R. Nasu, J. Nagai, and M. Takano Pharmacokinetic Interaction of Cytochrome P450 3A-Related Compounds with Rhodamine 123, a P-Glycoprotein Substrate, in Rats Pretreated with Dexamethasone Drug Metab. Dispos., February 1, 2001; 29(2): 145 - 151. [Abstract] [Full Text] |
||||
![]() |
D. Schwab, A. W. Herling, H. Hemmerle, G. Schubert, B. Hagenbuch, and H.-J. Burger Hepatic Uptake of Synthetic Chlorogenic Acid Derivatives by the Organic Anion Transport Proteins J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 91 - 98. [Abstract] [Full Text] |
||||
![]() |
H. Kouzuki, H. Suzuki, B. Stieger, P. J. Meier, and Y. Sugiyama Characterization of the Transport Properties of Organic Anion Transporting Polypeptide 1 (oatp1) and Na+/Taurocholate Cotransporting Polypeptide (Ntcp): Comparative Studies on the Inhibitory Effect of their Possible Substrates in Hepatocytes and cDNA-Transfected COS-7 Cells J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 505 - 511. [Abstract] [Full Text] |
||||
![]() |
M. Cvetkovic, B. Leake, M. F. Fromm, G. R. Wilkinson, and R. B. Kim OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine Drug Metab. Dispos., August 1, 1999; 27(8): 866 - 871. [Abstract] [Full Text] |
||||
![]() |
U. Eckhardt, A. Schroeder, B. Stieger, M. Hochli, L. Landmann, R. Tynes, P. J. Meier, and B. Hagenbuch Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1037 - G1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tan, R. G. Tirona, and K. S. Pang Lack of Zonal Uptake of Estrone Sulfate in Enriched Periportal and Perivenous Isolated Rat Hepatocytes Drug Metab. Dispos., March 1, 1999; 27(3): 336 - 341. [Abstract] [Full Text] |
||||
![]() |
H. Kouzuki, H. Suzuki, K. Ito, R. Ohashi, and Y. Sugiyama Contribution of Sodium Taurocholate Co-Transporting Polypeptide to the Uptake of Its Possible Substrates Into Rat Hepatocytes J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1043 - 1050. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |